Delivery Order SPE2DB25D3003-SPE2DB25FPXAK
- Not listed
- The Defense Logistics Agency awarded a $3,103.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Cipro 5% Suspension in 100ml quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for ciprofloxacin hydrochloride 500 mg tablets (100 count) with a ceiling value of $1,031.40. The contract was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and utilizes firm fixed pricing with no set-aside designation. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML with a ceiling value of $1,079.02. This firm fixed-price, competitively awarded delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, valued at $999.99 billion through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cipro 5% suspension in 100ml quantities, with a ceiling value of $1,332.60 under a firm fixed-price contract structure. This non-competitive delivery order was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery supports the federal...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 30, 2025, for Ciprofloxacin HCL 500 mg tablets (100-count) with a ceiling value of $1,877.16. This firm fixed-price delivery order, with completion targeted for July 31, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and primary pharmaceutical distributor for this...
- The Defense Logistics Agency awarded a delivery order valued at $4,210.72 to AmerisourceBergen Drug Corp for Cipro 10% Suspension 100ML, a broad-spectrum antibiotic pharmaceutical product. The contract utilized firm fixed price pricing with no set-aside designation, indicating competitive award through an open procurement process. The delivery order is scheduled for completion by August 1, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Cipro 500 mg tablets (100-count units) at a ceiling value of $1,185.69. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 14, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, for the supply of Ciprofloxacin HCl 500 mg tablets (100-count) with a ceiling value of $2,885.17. This competitively awarded, firm fixed-price contract is scheduled for completion by August 14, 2025, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets in quantities of 100, with a ceiling value of $1,019.21. This is a firm fixed price, non-set-aside delivery order that will be completed by August 28, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,240.05 to AmerisourceBergen Drug Corp for CIPRO 5% Suspension 100ML, a fluoroquinolone antibiotic commonly used to treat bacterial infections across military and federal healthcare systems. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPXAKDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,649.57 by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Cipro 5% Suspension in 100ml units. This competitive award employs firm fixed-price pricing and carries an ultimate completion date of August 28, 2025, with no set-aside designation. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle running through December 2026 that enables the company to provide a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. This delivery order supports the Defense Logistics Agency's mission to supply critical pharmaceutical products to Department of Defense healthcare systems, including the Defense Health Agency and other military medical facilities. Ciprofloxacin suspension is a widely-used broad-spectrum antibiotic essential for military medical operations. AmerisourceBergen's selection through competitive procurement reflects its established capability as a major pharmaceutical distributor and prime vendor for federal medical supply chains, reinforcing its role as a key supplier for military healthcare logistics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/27/25 |